Innate Pharma SA IDD-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:03 AM CEST
3.03quote price arrow down-0.05 (-1.49%)
52 week range
2.95 - 6.04

...

Loading . . .
  • Open3.03
  • Day High3.03
  • Day Low3.03
  • Prev Close3.08
  • 52 Week High6.04
  • 52 Week High Date06/25/20
  • 52 Week Low2.95
  • 52 Week Low Date06/03/21

Key Stats

  • Market Cap311.09M
  • Shares Out78.97M
  • 10 Day Average Volume609.2
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-10.18

KEY STATS

  • Open3.03
  • Day High3.03
  • Day Low3.03
  • Prev Close3.08
  • 52 Week High6.04
  • 52 Week High Date06/25/20
  • 52 Week Low2.95
  • 52 Week Low Date06/03/21
  • Market Cap311.09M
  • Shares Out78.97M
  • 10 Day Average Volume609.2
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-10.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.81
  • P/E (TTM)-3.75
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Innate Pharma SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic...
Laure-Helene Mercier
Chief Financial Officer
Yannis Morel Ph.D.
Executive Vice President
Joyson Karakunnel
Executive Vice President
Jennifer Butler
Executive Vice President
Odile Belzunce
Vice President
Address
117 avenue de Luminy, Bp 30191
Marseille
13009
France